Table 1.
HPV prevalence in different age groups.
| Characteristics | <20, (n%; 95% CI) | 20–29, (n%; 95% CI) | 30–39, (n%; 95% CI) | 40–49, (n%; 95% CI) | 50–59, (n%; 95% CI) | 60–69, (n%; 95% CI) | >70, (n%; 95% CI) | Total, (n%; 95% CI) |
|---|---|---|---|---|---|---|---|---|
| High-risk HPV positive | 89 (77.39; 68.65–84.67) | 762 (84.29; 81.75–86.60) | 1,520 (85.01; 83.27–86.64) | 1,852 (83.91; 82.31–85.42) | 1,397 (86.77; 85.02–88.39) | 507 (90.70; 87.98–92.70) | 93 (90.29; 82.87–95.25) | 6,220 (85.37; 84.54–86.17) |
| Low-risk HPV positive only | 26 (22.61; 15.33–31.35) | 142 (15.71; 13.40–18.25) | 268 (14.99; 13.36–16.73) | 355 (16.09; 14.58–17.69) | 213 (13.23; 11.61–14.98) | 52 (9.30; 7.03–12.02) | 10 (9.71; 4.75–17.13) | 1,066 (14.63; 13.83–15.46) |
| Total HPV positive | 115 (27.32; 23.11–31.84) | 904 (13.14; 12.35–13.96) | 1,788 (13.04; 12.48–13.61) | 2,207 (13.26; 12.75–13.79) | 1,610 (17.25; 16.49–18.03) | 559 (22.93; 21.27–24.64) | 103 (19.73; 16.40–23.41) | 7,286 (14.59; 14.28–14.90) |
| Negative | 306 (72.68; 68.16–76.89) | 5,978 (86.86; 86.04–87.65) | 11,928 (86.96; 86.39–87.52) | 14,436 (86.74; 86.21–87.25) | 7,723 (82.75; 81.97–83.51) | 1,879 (77.07; 75.35–78.72) | 419 (80.27; 76.59–83.60) | 42,669 (85.41; 85.10–85.72) |
| 421 | 6,882 | 13,716 | 16,643 | 9,333 | 2,438 | 522 | 49,955 |